Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2002 1
2003 5
2004 2
2005 5
2006 1
2007 2
2008 5
2009 12
2010 10
2011 5
2012 13
2013 12
2014 9
2015 7
2016 7
2017 5
2018 3
2019 10
2020 5
2021 8
2022 5
2023 9
2024 12
2025 12
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean buhler eb (3 results)?
Adalimumab in Patients with Active Noninfectious Uveitis.
Jaffe GJ, Dick AD, Brézin AP, Nguyen QD, Thorne JE, Kestelyn P, Barisani-Asenbauer T, Franco P, Heiligenhaus A, Scales D, Chu DS, Camez A, Kwatra NV, Song AP, Kron M, Tari S, Suhler EB. Jaffe GJ, et al. Among authors: suhler eb. N Engl J Med. 2016 Sep 8;375(10):932-43. doi: 10.1056/NEJMoa1509852. N Engl J Med. 2016. PMID: 27602665 Free article. Clinical Trial.
Drug-induced uveitis.
Shifera AS, Kopplin L, Lin P, Suhler EB. Shifera AS, et al. Among authors: suhler eb. Int Ophthalmol Clin. 2015 Spring;55(2):47-65. doi: 10.1097/IIO.0000000000000059. Int Ophthalmol Clin. 2015. PMID: 25730619 Review. No abstract available.
Rituximab for Ocular Inflammatory Disease.
Cunningham ET Jr, Ng C, Suhler EB, Smit DP. Cunningham ET Jr, et al. Among authors: suhler eb. Ocul Immunol Inflamm. 2022 Aug;30(6):1300-1302. doi: 10.1080/09273948.2022.2141034. Ocul Immunol Inflamm. 2022. PMID: 36379016 No abstract available.
Epidemiology of Intermediate Uveitis.
Besagar S, de-la-Torre A, Thorne J, Biswas J, Agrawal R, Suhler EB, Kempen JH, Gangaputra S. Besagar S, et al. Among authors: suhler eb. Ocul Immunol Inflamm. 2025 May;33(4):503-511. doi: 10.1080/09273948.2024.2408411. Epub 2024 Oct 3. Ocul Immunol Inflamm. 2025. PMID: 39360991 Free article. Review.
Adalimumab for Ocular Inflammation.
Durrani K, Kempen JH, Ying GS, Kacmaz RO, Artornsombudh P, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Foster CS Md Facs, Systemic Immunosuppressive Therapy For Eye Diseases Site Research Group. Durrani K, et al. Among authors: suhler eb. Ocul Immunol Inflamm. 2017 Jun;25(3):405-412. doi: 10.3109/09273948.2015.1134581. Epub 2016 Mar 22. Ocul Immunol Inflamm. 2017. PMID: 27003323 Free PMC article.
Filgotinib in Active Noninfectious Uveitis: The HUMBOLDT Randomized Clinical Trial.
Srivastava SK, Watkins TR, Nguyen QD, Sharma S, Scales DK, Dacey MS, Shah RE, Chu DS, Grewal DS, Faia LJ, Suhler EB, Genovese MC, Guo Y, Barchuk WT, Besuyen R, Dick AD, Rosenbaum JT. Srivastava SK, et al. Among authors: suhler eb. JAMA Ophthalmol. 2024 Sep 1;142(9):789-797. doi: 10.1001/jamaophthalmol.2024.2439. JAMA Ophthalmol. 2024. PMID: 39023880 Free PMC article. Clinical Trial.
The future of uveitis treatment.
Lin P, Suhler EB, Rosenbaum JT. Lin P, et al. Among authors: suhler eb. Ophthalmology. 2014 Jan;121(1):365-376. doi: 10.1016/j.ophtha.2013.08.029. Epub 2013 Oct 26. Ophthalmology. 2014. PMID: 24169255 Free PMC article. Review.
The Rate of Failure of Trabeculectomy and Tube Shunt Surgery in Eyes with Uveitic Glaucoma and Ocular Hypertension.
Groth SL, Newcomb CW, Yang W, Payal A, Begum H, Khachatryan N, Kaçmaz RO, Dreger KA, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Levy-Clarke GA, Buchanich JM, Ying GS, Kempen JH, Gangaputra S; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Research Group. Groth SL, et al. Among authors: suhler eb. Ophthalmol Glaucoma. 2025 Nov-Dec;8(6):580-588. doi: 10.1016/j.ogla.2025.05.004. Epub 2025 May 22. Ophthalmol Glaucoma. 2025. PMID: 40412807 Free article.
Outcomes in Patients With Vogt-Koyanagi-Harada Disease From the First-Line Antimetabolites for Steroid-Sparing Treatment Uveitis Trial.
Acharya NR, Rathinam SR, Thundikandy R, Kanakath A, Murugan SB, Vedhanayaki R, Gonzales JA, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Arellanes-Garcia L, Coyne A, Porco TC, Shantha JG; FAST Research Group. Acharya NR, et al. Among authors: suhler eb. Am J Ophthalmol. 2024 Nov;267:100-111. doi: 10.1016/j.ajo.2024.06.004. Epub 2024 Jun 22. Am J Ophthalmol. 2024. PMID: 38909740 Clinical Trial.
140 results